Cargando…
Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity
Dendritic cells (DCs) are professional antigen-presenting cells that play an important role in both innate and acquired immune responses against pathogens. However, the role of DCs in coronavirus disease 2019 (COVID-19) is unclear. Virus-like particles (VLPs) that structurally mimic the original vir...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682005/ https://www.ncbi.nlm.nih.gov/pubmed/36439228 http://dx.doi.org/10.3389/fcimb.2022.986350 |
_version_ | 1784834750410653696 |
---|---|
author | Mi, Youjun Liang, Lijuan Xu, Kun Li, Qing Wang, Wenting Dang, Wenrui Deng, Jiahui Zhi, Yucheng Li, Xuefeng Tan, Jiying |
author_facet | Mi, Youjun Liang, Lijuan Xu, Kun Li, Qing Wang, Wenting Dang, Wenrui Deng, Jiahui Zhi, Yucheng Li, Xuefeng Tan, Jiying |
author_sort | Mi, Youjun |
collection | PubMed |
description | Dendritic cells (DCs) are professional antigen-presenting cells that play an important role in both innate and acquired immune responses against pathogens. However, the role of DCs in coronavirus disease 2019 (COVID-19) is unclear. Virus-like particles (VLPs) that structurally mimic the original virus are one of the candidates COVID-19 vaccines. In the present study, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) VLPs were used as an alternative to live virus to evaluate the interaction of the virus with DCs. The results revealed that SARS-CoV-2 VLPs induced DC maturation by augmenting cell surface molecule expression (CD80, CD86, and major histocompatibility complex class II (MHC-II)) and inflammatory cytokine production (tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and IL-12p70) in DCs via the mitogen-activated protein kinase and nuclear factor-κB signaling pathways. In addition, mature DCs induced by SARS-CoV-2 VLPs promoted T cell proliferation, which was dependent on VLPs concentration. Our results suggest that SARS-CoV-2 VLPs regulate the immune response by interacting with DCs. These findings will improve the understanding of SARS-CoV-2 pathogenesis and SARS-CoV-2 vaccine development. |
format | Online Article Text |
id | pubmed-9682005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96820052022-11-24 Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity Mi, Youjun Liang, Lijuan Xu, Kun Li, Qing Wang, Wenting Dang, Wenrui Deng, Jiahui Zhi, Yucheng Li, Xuefeng Tan, Jiying Front Cell Infect Microbiol Cellular and Infection Microbiology Dendritic cells (DCs) are professional antigen-presenting cells that play an important role in both innate and acquired immune responses against pathogens. However, the role of DCs in coronavirus disease 2019 (COVID-19) is unclear. Virus-like particles (VLPs) that structurally mimic the original virus are one of the candidates COVID-19 vaccines. In the present study, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) VLPs were used as an alternative to live virus to evaluate the interaction of the virus with DCs. The results revealed that SARS-CoV-2 VLPs induced DC maturation by augmenting cell surface molecule expression (CD80, CD86, and major histocompatibility complex class II (MHC-II)) and inflammatory cytokine production (tumor necrosis factor-α, interleukin (IL)-1β, IL-6, and IL-12p70) in DCs via the mitogen-activated protein kinase and nuclear factor-κB signaling pathways. In addition, mature DCs induced by SARS-CoV-2 VLPs promoted T cell proliferation, which was dependent on VLPs concentration. Our results suggest that SARS-CoV-2 VLPs regulate the immune response by interacting with DCs. These findings will improve the understanding of SARS-CoV-2 pathogenesis and SARS-CoV-2 vaccine development. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9682005/ /pubmed/36439228 http://dx.doi.org/10.3389/fcimb.2022.986350 Text en Copyright © 2022 Mi, Liang, Xu, Li, Wang, Dang, Deng, Zhi, Li and Tan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Mi, Youjun Liang, Lijuan Xu, Kun Li, Qing Wang, Wenting Dang, Wenrui Deng, Jiahui Zhi, Yucheng Li, Xuefeng Tan, Jiying Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity |
title | Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity |
title_full | Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity |
title_fullStr | Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity |
title_full_unstemmed | Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity |
title_short | Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity |
title_sort | severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate t cell immunity |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682005/ https://www.ncbi.nlm.nih.gov/pubmed/36439228 http://dx.doi.org/10.3389/fcimb.2022.986350 |
work_keys_str_mv | AT miyoujun severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT lianglijuan severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT xukun severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT liqing severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT wangwenting severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT dangwenrui severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT dengjiahui severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT zhiyucheng severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT lixuefeng severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity AT tanjiying severeacuterespiratorysyndromecoronavirus2viruslikeparticlesinducedendriticcellmaturationandmodulatetcellimmunity |